Literature DB >> 1519959

Sequelae of haemolytic uraemic syndrome.

A Schlieper1, P C Rowe, E Orrbine, M Zoubek, W Clark, N Wolfish, P N McLaine.   

Abstract

Twenty two patients with previous episodes of haemolytic uraemic syndrome (HUS) were investigated for evidence of deficits in cognitive, behavioural, and academic function. Patients were pair matched with 22 controls for age (+/- 1 year), gender, and socioeconomic status. HUS patients had numerically lower cognitive and achievement scores and higher behavioural problem ratings than their controls on every measure. None of the group differences was significant at the 0.01 level. Significance values between 0.10 and 0.01 were obtained for the Wechsler full scale and verbal intelligence quotient scores and for several of the achievement measures and behaviour ratings. These results were conservatively interpreted as trends and are considered to provide preliminary indications of a post-HUS deficit in behaviour, verbal intelligence, and the verbally based skills of reading comprehension and vocabulary. The findings provide interim guidelines for follow up care but require confirmation and elaboration in a larger study.

Entities:  

Mesh:

Year:  1992        PMID: 1519959      PMCID: PMC1793833          DOI: 10.1136/adc.67.7.930

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  19 in total

1.  The sequelae of Haemophilus influenzae meningitis in school-age children.

Authors:  H G Taylor; E L Mills; A Ciampi; R du Berger; G V Watters; R Gold; N MacDonald; R H Michaels
Journal:  N Engl J Med       Date:  1990-12-13       Impact factor: 91.245

2.  THE HEMOLYTIC-UREMIC SYNDROME.

Authors:  C GIANANTONIO; M VITACCO; F MENDILAHARZU; A RUTTY; J MENDILAHARZU
Journal:  J Pediatr       Date:  1964-04       Impact factor: 4.406

3.  The growing use of postal codes in health research.

Authors:  R Nadwodny
Journal:  Can J Public Health       Date:  1990 May-Jun

4.  The increasing incidence of the hemolytic-uremic syndrome in King County, Washington: lack of evidence for ascertainment bias.

Authors:  P I Tarr; M A Neill; J Allen; C J Siccardi; S L Watkins; R O Hickman
Journal:  Am J Epidemiol       Date:  1989-03       Impact factor: 4.897

5.  Large thrombotic strokes in hemolytic-uremic syndrome.

Authors:  E Trevathan; E C Dooling
Journal:  J Pediatr       Date:  1987-12       Impact factor: 4.406

6.  The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota.

Authors:  D L Martin; K L MacDonald; K E White; J T Soler; M T Osterholm
Journal:  N Engl J Med       Date:  1990-10-25       Impact factor: 91.245

7.  A clinicopathological study of 24 children with hemolytic uremic syndrome. A report of the Southwest Pediatric Nephrology Study Group.

Authors:  J C Argyle; R J Hogg; T J Pysher; F G Silva; R L Siegler
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

8.  A population-based study of hemolytic-uremic syndrome in Oregon, 1979-1982.

Authors:  M F Rogers; G W Rutherford; S R Alexander; J H DiLiberti; L Foster; L B Schonberger; E S Hurwitz
Journal:  Am J Epidemiol       Date:  1986-01       Impact factor: 4.897

9.  Neurological involvement in hemolytic-uremic syndrome.

Authors:  K J Sheth; H M Swick; N Haworth
Journal:  Ann Neurol       Date:  1986-01       Impact factor: 10.422

10.  Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988. The Canadian Pediatric Kidney Disease Reference Centre.

Authors:  P C Rowe; E Orrbine; G A Wells; P N McLaine
Journal:  J Pediatr       Date:  1991-08       Impact factor: 4.406

View more
  9 in total

1.  Escherichia coli O157:H7, other verotoxin-producing E coli and the hemolytic uremic syndrome in childhood.

Authors:  P C Rowe
Journal:  Can J Infect Dis       Date:  1995-03

Review 2.  Guidelines for the management and investigation of hemolytic uremic syndrome.

Authors:  Takashi Igarashi; Shuichi Ito; Mayumi Sako; Akihiko Saitoh; Hiroshi Hataya; Masashi Mizuguchi; Tsuneo Morishima; Kenji Ohnishi; Naohisa Kawamura; Hirotsugu Kitayama; Akira Ashida; Shinya Kaname; Hiromichi Taneichi; Julian Tang; Makoto Ohnishi
Journal:  Clin Exp Nephrol       Date:  2014-08       Impact factor: 2.801

3.  Long-term health-related quality of life and psychological adjustment in children after haemolytic-uraemic syndrome.

Authors:  Helene Werner; Kathrin Buder; Markus A Landolt; Thomas J Neuhaus; Guido F Laube; Giuseppina Spartà
Journal:  Pediatr Nephrol       Date:  2016-12-23       Impact factor: 3.714

4.  Neuropsychological sequelae of haemolytic uraemic syndrome. Investigators of the HUS Cognitive Study.

Authors:  A Schlieper; E Orrbine; G A Wells; M Clulow; P N McLaine; P C Rowe
Journal:  Arch Dis Child       Date:  1999-03       Impact factor: 3.791

Review 5.  Long-term outcomes of Shiga toxin hemolytic uremic syndrome.

Authors:  Joann M Spinale; Rebecca L Ruebner; Lawrence Copelovitch; Bernard S Kaplan
Journal:  Pediatr Nephrol       Date:  2013-01-04       Impact factor: 3.714

6.  Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS).

Authors:  Myda Khalid; Sharon Andreoli
Journal:  Pediatr Nephrol       Date:  2018-11-01       Impact factor: 3.714

7.  Neurological involvement in children with E. coli O104:H4-induced hemolytic uremic syndrome.

Authors:  Angela Bauer; Sebastian Loos; Carola Wehrmann; Dirk Horstmann; Frank Donnerstag; Johanna Lemke; Georg Hillebrand; Ulrike Löbel; Lars Pape; Dieter Haffner; Carola Bindt; Thurid Ahlenstiel; Anette Melk; Anja Lehnhardt; Markus J Kemper; Jun Oh; Hans Hartmann
Journal:  Pediatr Nephrol       Date:  2014-03-25       Impact factor: 3.714

Review 8.  Extrarenal involvement in diarrhoea-associated haemolytic-uraemic syndrome.

Authors:  E G Gallo; C A Gianantonio
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

9.  Neuropsychological outcome after complicated Shiga toxin-producing Escherichia coli infection.

Authors:  Olga Simova; Gabriele Weineck; Thorsten Schuetze; Karl Wegscheider; Ulf Panzer; Rolf A K Stahl; Christian Gerloff; Tim Magnus
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.